Remy A. Pollock

1.2k total citations
21 papers, 653 citations indexed

About

Remy A. Pollock is a scholar working on Immunology, Hematology and Rheumatology. According to data from OpenAlex, Remy A. Pollock has authored 21 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 11 papers in Hematology and 10 papers in Rheumatology. Recurrent topics in Remy A. Pollock's work include Psoriasis: Treatment and Pathogenesis (13 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Spondyloarthritis Studies and Treatments (9 papers). Remy A. Pollock is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Autoimmune and Inflammatory Disorders Research (11 papers) and Spondyloarthritis Studies and Treatments (9 papers). Remy A. Pollock collaborates with scholars based in Canada, United States and United Kingdom. Remy A. Pollock's co-authors include Dafna D. Gladman, Vinod Chandran, Fatima Abji, Fawnda Pellett, Lihi Eder, Kun Liang, Cheryl F. Rosen, Arane Thavaneswaran, Jai Jayakar and Proton Rahman and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and British Journal of Dermatology.

In The Last Decade

Remy A. Pollock

21 papers receiving 642 citations

Peers

Countries citing papers authored by Remy A. Pollock

Since Specialization

Citations

This map shows the geographic impact of Remy A. Pollock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remy A. Pollock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remy A. Pollock more than expected).

Fields of papers citing papers by Remy A. Pollock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remy A. Pollock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remy A. Pollock. The network helps show where Remy A. Pollock may publish in the future.

Co-authorship network of co-authors of Remy A. Pollock

This figure shows the co-authorship network connecting the top 25 collaborators of Remy A. Pollock. A scholar is included among the top collaborators of Remy A. Pollock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remy A. Pollock. Remy A. Pollock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension 2023 ·RMD Open ·Lihi Eder, Dafna D. Gladman, Philip J. Mease, Remy A. Pollock, (unknown), Sibel Zehra Aydın, Alexis Ogdie, Ari Polachek, David Gruben, (unknown), (unknown), Vibeke Strand	14
2	Exploring cannabis use and perspectives among psoriatic disease patients 2022 ·Clinical Rheumatology ·(unknown), (unknown), (unknown), Remy A. Pollock, Daniel Pereira, (unknown), Dafna D. Gladman, Cheryl F. Rosen	4
3	Declining levels of serum chemokine (C‐X‐C motif) ligand 10 over time are associated with new onset of psoriatic arthritis in patients with psoriasis: a new biomarker?* 2020 ·British Journal of Dermatology ·Fatima Abji, Ker‐Ai Lee, Remy A. Pollock, (unknown), Richard J. Cook, Vinod Chandran, Dafna D. Gladman	14
4	Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis 2019 ·PLoS ONE ·Remy A. Pollock, (unknown), Vinod Chandran, Dafna D. Gladman	24
5	FRI0358 ROLE OF MIRNA-21-5PAS A POTENTIAL BIOMARKER FOR THE INFLAMMATION PATHWAY IN PSORIATIC DISEASE AND RESPONSE TO METHOTREXATE TREATMENT 2019 ·Annals of the Rheumatic Diseases ·(unknown), Remy A. Pollock, (unknown), Vinod Chandran, Dafna D. Gladman	1
6	OP0203 CHARACTERIZING THE EPIGENOMIC LANDSCAPE OF PSORIASIS PATIENTS DESTINED TO DEVELOP PSORIATIC ARTHRITIS 2019 ·Annals of the Rheumatic Diseases ·Remy A. Pollock, (unknown), Vinod Chandran, Dafna D. Gladman	2
7	Th17 gene expression in psoriatic arthritis synovial fluid and peripheral blood compared to osteoarthritis and cutaneous psoriasis. 2018 ·PubMed ·Fatima Abji, Remy A. Pollock, Kun Liang, Vinod Chandran, Dafna D. Gladman	14
8	Association of variably expressed KIR3dl1 alleles with psoriatic disease 2017 ·Clinical Rheumatology ·Jeffrey Berinstein, Remy A. Pollock, Fawnda Pellett, Arane Thavaneswaran, Vinod Chandran, Dafna D. Gladman	14
9	Epigenetics of psoriatic disease: A systematic review and critical appraisal 2016 ·Journal of Autoimmunity ·Remy A. Pollock, Fatima Abji, Dafna D. Gladman	69
10	Differential gene and protein expression of chemokines and cytokines in synovial fluid of patients with arthritis 2016 ·Arthritis Research & Therapy ·Anastasiya Muntyanu, Fatima Abji, Kun Liang, Remy A. Pollock, Vinod Chandran, Dafna D. Gladman	29
11	Brief Report: CXCL10 Is a Possible Biomarker for the Development of Psoriatic Arthritis Among Patients With Psoriasis 2016 ·Arthritis & Rheumatology ·Fatima Abji, Remy A. Pollock, Kun Liang, Vinod Chandran, Dafna D. Gladman	67
12	Further Evidence Supporting a Parent‐of‐Origin Effect in Psoriatic Disease 2015 ·Arthritis Care & Research ·Remy A. Pollock, Arane Thavaneswaran, Fawnda Pellett, Vinod Chandran, Artūras Petronis, Proton Rahman, Dafna D. Gladman	13
13	AB0160 Epigenetic Studies in Maternally versus Paternally Transmitted Psoriatic Disease 2014 ·Annals of the Rheumatic Diseases ·Darren D. O’Rielly, Remy A. Pollock, (unknown), (unknown), (unknown), Sean Hamilton, (unknown), Vinod Chandran, (unknown), Dafna D. Gladman, Guangju Zhai, Proton Rahman	5
14	Soluble Biomarkers Associated with Response to Treatment with Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis 2013 ·The Journal of Rheumatology ·Vinod Chandran, Hua Shen, Remy A. Pollock, Fawnda Pellett, Adele Carty, Richard J. Cook, Dafna D. Gladman	43
15	Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis 2013 ·Lara D. Veeken ·V. Chandran, Shelley B. Bull, Fawnda Pellett, Renise Ayearst, Remy A. Pollock, Dafna D. Gladman	42
16	The functional MICA‐129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA‐B and HLA‐C 2013 ·Tissue Antigens ·Remy A. Pollock, Vinod Chandran, Fawnda Pellett, Arane Thavaneswaran, Lihi Eder, John Barrett, Proton Rahman, Vernon T. Farewell, Dafna D. Gladman	27
17	Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity 2012 ·Annals of the Rheumatic Diseases ·Lihi Eder, Jai Jayakar, Remy A. Pollock, Fawnda Pellett, Arane Thavaneswaran, Vinod Chandran, Cheryl F. Rosen, Dafna D. Gladman	98
18	Differential major histocompatibility complex class I chain‐related A allele associations with skin and joint manifestations of psoriatic disease 2011 ·Tissue Antigens ·Remy A. Pollock, Vinod Chandran, John Barrett, Lihi Eder, Fawnda Pellett, Christopher M. K. L. Yao, Marsel Lino, (unknown), Vernon T. Farewell, Dafna D. Gladman	24
19	IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients 2011 ·Annals of the Rheumatic Diseases ·Lihi Eder, Vinod Chandran, Fawnda Pellett, Remy A. Pollock, (unknown), Cheryl F. Rosen, Proton Rahman, Dafna D. Gladman	56
20	Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae 2009 ·BMC Genomics ·Dylan R. Pillai, Dea Shahinas, Alla Buzina, Remy A. Pollock, Rachel Lau, Krishna Khairnar, A. Y. Wong, David J. Farrell, Karen Green, Allison McGeer, Donald E. Low	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact